A clinical study to find out the effectiveness of Homoeopathic Medicine in the management of Pityriasis Versicolor

A clinical Study to determine the effectiveness of Individualized Homoeopathic Medicine in the management of Pityriasis Versicolor - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060024

Enrollment

Registered

2023-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B360- Pityriasis versicolor

Interventions

Intervention1: Individualized Homoeopathic Medicine: Administering Individualized Homoeopathic Medicine for the Management of Pityriasis Versicolor for a time period of one year Control Intervention1:

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with typical hypopigmented or hyperpigmented macules, scales, pruritis and erythema. 2.Patients confirmed by microscopic KOH test.

Exclusion criteria

Exclusion criteria: 1.Patients with co-existing dermatological conditions 2.Pregnant and lactating women 3. Patients with advanced systemic illnesses.

Design outcomes

Primary

Measure	Time frame
Changes in signs and symptoms of Pityriasis versicolor using TSSSTimepoint: One year	—

Secondary

Measure	Time frame
Changes in Skindex-16 scoreTimepoint: One year	—

Countries

India

Contacts

Public ContactDr P Dastagiri

National Homoeopathy Research Institute in Mental Health

drdastagirinhrimh@gmail.com9000444409

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026